Ausgabe 2/2019
Inhalt (5 Artikel)
Real World Evidence: Can We Really Expect It to Have Much Influence?
- Open Access
- Editorial
Keith Evans
A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough
- Open Access
- Review Article
Victor S. Sloan, Alphia Jones, Chidi Maduka, Jürgen W. G. Bentz
Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study
- Open Access
- Original Research Article
Kazeem A. Oshikoya, Robert Carroll, Ida Aka, Dan M. Roden, Sara L. Van Driest
Prevalence of Psychotropic Polypharmacy and Associated Healthcare Resource Utilization during Initial Phase of Care among Adults with Cancer in USA
- Open Access
- Original Research Article
Hilary A. Aroke, Ami M. Vyas, Ashley L. Buchanan, Stephen J. Kogut
A Pilot Study to Assess the Feasibility of a Web-Based Survey to Examine Patient-Reported Symptoms and Satisfaction in Patients with Ankylosing Spondylitis Receiving Secukinumab
- Open Access
- Original Research Article
Marina Magrey, Michael Bozyczko, Daniel Wolin, Margaret Mordin, Lori McLeod, Eric Davenport, Costel Chirila, Yujin Park